Pharmacologic inhibition of the Bcr-Abl kinase with STI571: a novel, safe, and effective therapy for chronic myeloid leukemia.

R. D. Press

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Pharmacologic inhibition of the Bcr-Abl kinase with STI571: a novel, safe, and effective therapy for chronic myeloid leukemia.'. Together they form a unique fingerprint.